Management of the axilla following neoadjuvant chemotherapy for breast cancer- A change in practice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of the axilla following neoadjuvant chemotherapy for breast cancer- A change in practice

Published:2021-02 Issue:1 Volume:19 Page:1-7
ISSN:1479-666X
Container-title:The Surgeon
language:en
Short-container-title:The Surgeon

Author:

Riogi Bahaty^ORCID,Sripadam Raj,Barker David,Harris Olga,Innes Helen,Chagla Leena

Publisher

Elsevier BV

Subject

Surgery

Reference25 articles.

1. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer;Fisher;J Clin Oncol,1998

2. Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy;Hennessy;J Clin Oncol,2005

3. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18;Fisher;J Clin Oncol,1997

4. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial;Mansel;JNCI J Natl Cancer Inst,2006

5. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer;Brady;Breast J,2002

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Sentinel Lymph Node Biopsy in Breast Cancer Patients Who Become Clinically Node-Negative Following Neo-Adjuvant Chemotherapy: A Literature Review;Current Oncology;2023-09-25

2. Absence of post-treatment changes in sentinel lymph nodes does not translate into increased regional recurrence rate in initially node-positive breast cancer patients;Breast Cancer Research and Treatment;2023-09-07

3. Absence of post-treatment changes in sentinel lymph nodes does not translate into increased regional recurrence rate in initially node positive breast cancer patients;2023-06-01

4. Retrospective study to assess axillary management and oncological outcome after neoadjuvant chemotherapy for patients with breast cancer;EGYPT J SURG;2022

5. Defining the Target Volumes and Radiation Doses after Primary Systemic Therapy;Breast Cancer Radiation Therapy;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3